ITGR Quote, Financials, Valuation and Earnings

Boston Scientific has a net margin of -5.14% compared to Integer Holdings's net margin of 14.45%. Integer Holdings's return on equity of 4.85% beat Boston Scientific's return on equity of 9.57%.

Integer Holdings has a consensus price target of $147.88, signalling upside risk potential of 23.63%. On the other hand Boston Scientific has an analysts' consensus of $116.20 which suggests that it could grow by 12.87%. Given that Integer Holdings has higher upside potential than Boston Scientific, analysts believe Integer Holdings is more attractive than Boston Scientific.

Integer Holdings has a beta of 1.030, which suggesting that the stock is 3.045% more volatile than S&P 500. In comparison Boston Scientific has a beta of 0.685, suggesting its less volatile than the S&P 500 by 31.536%.

Integer Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Integer Holdings pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.

Integer Holdings quarterly revenues are $437.4M, which are smaller than Boston Scientific quarterly revenues of $4.7B. Integer Holdings's net income of -$22.5M is lower than Boston Scientific's net income of $674M. Notably, Integer Holdings's price-to-earnings ratio is 56.69x while Boston Scientific's PE ratio is 75.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Integer Holdings is 2.41x versus 8.73x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

Enovis has a net margin of -5.14% compared to Integer Holdings's net margin of -10.02%. Integer Holdings's return on equity of 4.85% beat Enovis's return on equity of -26.77%.

Integer Holdings has a consensus price target of $147.88, signalling upside risk potential of 23.63%. On the other hand Enovis has an analysts' consensus of $57.50 which suggests that it could grow by 58.75%. Given that Enovis has higher upside potential than Integer Holdings, analysts believe Enovis is more attractive than Integer Holdings.

Integer Holdings has a beta of 1.030, which suggesting that the stock is 3.045% more volatile than S&P 500. In comparison Enovis has a beta of 1.583, suggesting its more volatile than the S&P 500 by 58.325%.

Integer Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Enovis offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Integer Holdings pays -- of its earnings as a dividend. Enovis pays out -- of its earnings as a dividend.

Integer Holdings quarterly revenues are $437.4M, which are smaller than Enovis quarterly revenues of $558.8M. Integer Holdings's net income of -$22.5M is higher than Enovis's net income of -$56M. Notably, Integer Holdings's price-to-earnings ratio is 56.69x while Enovis's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Integer Holdings is 2.41x versus 0.94x for Enovis. Usually stocks with elevated PS ratios are considered overvalued.

Globus Medical has a net margin of -5.14% compared to Integer Holdings's net margin of 12.62%. Integer Holdings's return on equity of 4.85% beat Globus Medical's return on equity of 4.59%.

Integer Holdings has a consensus price target of $147.88, signalling upside risk potential of 23.63%. On the other hand Globus Medical has an analysts' consensus of $84.00 which suggests that it could grow by 44.4%. Given that Globus Medical has higher upside potential than Integer Holdings, analysts believe Globus Medical is more attractive than Integer Holdings.

Integer Holdings has a beta of 1.030, which suggesting that the stock is 3.045% more volatile than S&P 500. In comparison Globus Medical has a beta of 1.324, suggesting its more volatile than the S&P 500 by 32.371%.

Integer Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Globus Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Integer Holdings pays -- of its earnings as a dividend. Globus Medical pays out -- of its earnings as a dividend.

Integer Holdings quarterly revenues are $437.4M, which are smaller than Globus Medical quarterly revenues of $598.1M. Integer Holdings's net income of -$22.5M is lower than Globus Medical's net income of $75.5M. Notably, Integer Holdings's price-to-earnings ratio is 56.69x while Globus Medical's PE ratio is 43.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Integer Holdings is 2.41x versus 3.21x for Globus Medical. Usually stocks with elevated PS ratios are considered overvalued.

Masimo has a net margin of -5.14% compared to Integer Holdings's net margin of -45.89%. Integer Holdings's return on equity of 4.85% beat Masimo's return on equity of -39.91%.

Integer Holdings has a consensus price target of $147.88, signalling upside risk potential of 23.63%. On the other hand Masimo has an analysts' consensus of $182.07 which suggests that it could grow by 18.89%. Given that Integer Holdings has higher upside potential than Masimo, analysts believe Integer Holdings is more attractive than Masimo.

Integer Holdings has a beta of 1.030, which suggesting that the stock is 3.045% more volatile than S&P 500. In comparison Masimo has a beta of 1.229, suggesting its more volatile than the S&P 500 by 22.855%.

Integer Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Masimo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Integer Holdings pays -- of its earnings as a dividend. Masimo pays out -- of its earnings as a dividend.

Integer Holdings quarterly revenues are $437.4M, which are larger than Masimo quarterly revenues of $372M. Integer Holdings's net income of -$22.5M is higher than Masimo's net income of -$170.7M. Notably, Integer Holdings's price-to-earnings ratio is 56.69x while Masimo's PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Integer Holdings is 2.41x versus 4.21x for Masimo. Usually stocks with elevated PS ratios are considered overvalued.